STG-001

N/A

Report date: 2026/04/24 20:01:59
NME

Base Information

Drug NameSTG-001
Drug Alias NameSTG-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinol-binding protein 4 inhibitors
TargetsRetinol-binding protein 4
Therapy Area/IndicationsStargardt Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesStargazer Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStargazer Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsStargardt Disease

Other Information

ATC CodeN/A
Related LinksN/A